Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2007 Jul;93(7):864-6.
doi: 10.1136/hrt.2007.124305.

Commentary on NICE guidance for secondary prevention for patients following a myocardial infarction

J S Skinner  1 , R Minhas
Affiliations
Comment

Commentary on NICE guidance for secondary prevention for patients following a myocardial infarction

J S Skinner et al. Heart. 2007 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: Dr Skinner was the clinical advisor for the NICE guideline for secondary prevention after MI and both Dr Skinner and Dr Minhas were members of the Guideline Development Group. During the last five years, Dr Skinner has received travel grants to attend educational meetings from Novartis, Pfizer and Sanofi Synthelabo/Bristol Myers Squibb Pharmaceuticals, with none during the last two years. During the last 12 months Dr Minhas has not received any honoraria and travel grants and over the preceding four years has received honoraria and travel grants from several pharmaceutical companies that manufacture cardiovascular therapies.

Comment on

Similar articles

See all similar articles

Cited by

References

    1. National Institute for Health and Clinical Excellence Clinical guideline 48. MI: secondary prevention in primary and secondary care for patients following a myocardial infarction. London: NICE, 2007
    1. National Institute for Clinical Excellence Prophylaxis for patients who have experienced a myocardial infarction: drug treatment, cardiac rehabilitation and dietary manipulation. London: NICE, 2001
    1. Department of Health National Service Framework for coronary heart disease. London: Department of Health, 2000
    1. National Institute for Clinical Excellence TA080: Clopidogrel in the treatment of non‐ST‐segment‐elevation acute coronary syndrome. London: NICE, 2004
    1. National Institute for Health and Clinical Excellence Cardiovascular risk assessment: the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. Available at http://www.nice.org.uk/page.aspx?o = guidelines.inprogress.hyperlipidaemiacardiovascular (accessed February 2007)

Publication types

MeSH terms

Substances